The investment team seeks to invest in companies with franchise characteristics that are benefiting from an accelerating profit cycle and are trading at a discount to private market value.
As of 31 May 2022 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDSX | -16.29 | -31.40 | -32.75 | 5.27 | 10.06 | 11.78 | 9.00 |
Russell 2000® Growth Index | -13.93 | -24.79 | -25.71 | 6.18 | 6.87 | 10.55 | 7.39 |
Russell 2000® Index | -9.77 | -16.56 | -16.92 | 9.70 | 7.72 | 10.83 | 8.96 |
As of 31 March 2022 | QTD | YTD | 1 Yr | 3 Yr | 5 Yr | 10 Yr | Inception |
---|---|---|---|---|---|---|---|
Advisor Class: APDSX | -18.05 | -18.05 | -21.31 | 11.16 | 14.94 | 12.76 | 9.78 |
Russell 2000® Growth Index | -12.63 | -12.63 | -14.33 | 9.88 | 10.33 | 11.21 | 8.03 |
Russell 2000® Index | -7.53 | -7.53 | -5.79 | 11.74 | 9.74 | 11.04 | 9.43 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Advisor Class: APDSX | 26.96 | 2.38 | 40.33 | 61.19 | -8.77 |
Russell 2000® Growth Index | 22.17 | -9.31 | 28.48 | 34.63 | 2.83 |
Russell 2000® Index | 14.65 | -11.01 | 25.52 | 19.96 | 14.82 |
Semi-Annual Report 31 March 2022 | 1.06% |
---|---|
Prospectus 30 September 2021 | 1.06% |
Semi-Annual Report Figure(s): Unaudited, annualized for the six-month period. Prospectus Figures: See prospectus for further details.
Top 10 Holdings (% of total portfolio as of 31 May 2022) |
|
---|---|
Halozyme Therapeutics Inc (Health Care) | 8.5 |
Lattice Semiconductor Corp (Information Technology) | 5.3 |
Monolithic Power Systems Inc (Information Technology) | 4.9 |
Argenx SE (Health Care) | 4.4 |
Valmont Industries Inc (Industrials) | 4.2 |
Blackline Inc (Information Technology) | 4.0 |
Shockwave Medical Inc (Health Care) | 3.5 |
Ingersoll Rand Inc (Industrials) | 3.3 |
Ascendis Pharma A/S (Health Care) | 3.2 |
Novanta Inc (Information Technology) | 3.2 |
Total | 44.6% |
Portfolio Statistics (as of 31 May 2022) |
|
---|---|
Median Market Cap (Billions) | $3.9 |
Weighted Avg. Market Cap (Billions) | $7.2 |
Weighted Harmonic Avg. P/E (FY1) | 31.1X |
Weighted Harmonic Avg. P/E (FY2) | 26.9X |
Weighted Avg. LT EPS Growth Rate (3-5 Yr) | 19.0% |
Weighted Avg. LT Debt/Capital | 33.9% |
Active Share | 94.5% |
Annual Turnover | 39.8% |
Number of Securities | 63 |
Cash (% of total portfolio) | 1.0% |
Market Cap Distribution (% of portfolio securities as of 31 May 2022) $ in billions |
|
---|---|
5.8+ | 50.0 |
4.4–5.8 | 12.6 |
3.2–4.4 | 14.9 |
1.8–3.2 | 13.7 |
0.0–1.8 | 8.8 |
TOTAL | 100.0% |
Sector Diversification (% of portfolio securities as of 31 May 2022) |
|
---|---|
Communication Services | 1.3 |
Consumer Discretionary | 10.4 |
Consumer Staples | 0.8 |
Energy | — |
Financials | 3.8 |
Health Care | 29.9 |
Industrials | 12.2 |
Information Technology | 40.9 |
Materials | — |
Real Estate | 0.7 |
Utilities | — |
Total | 100.0% |